Literature DB >> 22129259

Suppressing immunosuppression after stroke.

Christian Meisel1, Andreas Meisel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22129259     DOI： 10.1056/NEJMcibr1112454

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

1.  Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke.

Authors:  Min-Gyu Park; Min-Kyeung Kim; Song-Hwa Chae; Hyung-Keun Kim; Junhee Han; Kyung-Pil Park
Journal:  Neurol Sci       Date:  2017-10-30       Impact factor: 3.307

2.  Blocking Sympathetic Nervous System Reverses Partially Stroke-Induced Immunosuppression but does not Aggravate Functional Outcome After Experimental Stroke in Rats.

Authors:  Qi-Wen Deng; Heng Yang; Fu-Ling Yan; Huan Wang; Fang-Lan Xing; Lei Zuo; Han-Qing Zhang
Journal:  Neurochem Res       Date:  2016-04-08       Impact factor: 3.996

3.  Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition.

Authors:  Baokai Dou; Shichun Li; Luyao Wei; Lixin Wang; Shiguo Zhu; Zhengtao Wang; Zunji Ke; Kaixian Chen; Zhifei Wang
Journal:  Front Med       Date:  2020-12-28       Impact factor: 4.592

Review 4.  Promises and limitations of immune cell-based therapies in neurological disorders.

Authors:  Xiaoming Hu; Rehana K Leak; Angus W Thomson; Fang Yu; Yuguo Xia; Lawrence R Wechsler; Jun Chen
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

5.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

6.  Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.

Authors:  Fang Zhang; Chen Yan; Changjuan Wei; Yang Yao; Xiaofeng Ma; Zhongying Gong; Shoufeng Liu; Dawei Zang; Jieli Chen; Fu-Dong Shi; Junwei Hao
Journal:  Transl Stroke Res       Date:  2017-07-09       Impact factor: 6.829

7.  Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies.

Authors:  Georg Royl; Tsafack Judicael Fokou; Rittika Chunder; Rakad Isa; Thomas F Münte; Klaus-Peter Wandinger; Markus Schwaninger; Oliver Herrmann; José Manuel Valdueza; Jan Brocke; Martin Willkomm; Dietrich Willemsen; Gerd U Auffarth; Swantje Mindorf; Britta Brix; Angel Chamorro; Anna Planas; Xabier Urra
Journal:  J Neurol       Date:  2019-07-29       Impact factor: 4.849

8.  Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone.

Authors:  S Yousuf; F Atif; I Sayeed; J Wang; D G Stein
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

9.  Sex-Related Differences in the Risk of Hospital-Acquired Sepsis and Pneumonia Post Acute Ischemic Stroke.

Authors:  James F Colbert; Richard J Traystman; Sharon N Poisson; Paco S Herson; Adit A Ginde
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-06-28       Impact factor: 2.136

10.  Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.

Authors:  Thorsten R Doeppner; Josephine Herz; André Görgens; Jana Schlechter; Anna-Kristin Ludwig; Stefan Radtke; Kyra de Miroschedji; Peter A Horn; Bernd Giebel; Dirk M Hermann
Journal:  Stem Cells Transl Med       Date:  2015-09-03       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.